Results 211 to 220 of about 4,391,476 (235)

Long-Term Costs of Treatment for Depression: Impact of Drug Selection and Guideline Adherence

, 2001
William H. Crown, Michael Treglia, Laurie Meneades, Amy White   +3 more
openalex   +1 more source

Layer-specific serotonergic induction of long-term depression in the prefrontal cortex of rats. [PDF]

Korean J Physiol Pharmacol, 2020
Shin D, Cho KH, Joo K, Rhie DJ.
europepmc   +1 more source

Permanent Depression of Plasma cGMP during Long-Term Space Flight

, 2001
Andreas Rössler, V. B. Noskov, Zsolt László, V V Polyakow, HG Hinghofer-Szalky   +4 more
openalex   +1 more source

Phosphorylation of Threonine-19 of PSD-95 by GSK-3β is Required for PSD-95 Mobilization and Long-Term Depression

Journal of Neuroscience, 2013
C. D. Nelson, M. J. Kim, H. Hsin, Yelin Chen, M. Sheng   +4 more
semanticscholar   +1 more source

Long-term depression triggers the selective elimination of weakly integrated synapses

Proceedings of the National Academy of Sciences of the United States of America, 2013
J. Simon Wiegert, T. Oertner
semanticscholar   +1 more source

Postsynaptic Density-95 Mimics and Occludes Hippocampal Long-Term Potentiation and Enhances Long-Term Depression

, 2003
Valentin Stein, David Richard Clermont House, David S. Bredt, Roger A. Nicoll   +3 more
openalex   +1 more source

Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression. I. Impact on maternal mood.

, 2003
Peter Cooper, Lynne Murray, Anji Wilson, Helena Romaniuk   +3 more
openalex  

Some of the next articles are maybe not open access.

Related searches:

Long-term safety of ketamine and esketamine in treatment of depression

Expert Opinion on Drug Safety, 2022
Introduction Ketamine can produce rapid-acting antidepressant effects. Esketamine (Spravato), the S-enantiomer of racemic ketamine, was approved by the FDA for treatment-resistant depression in 2019.
Sina Nikayin, Eva L. Murphy, J. Krystal, S. Wilkinson   +3 more
semanticscholar   +1 more source